IQVIA website | Customer Portal

IQVIA™ Real-World Insights Bibliography

Home

Search criteria

Condition: Obesity

Year -

Key

C = Condition
Y = Year
L = Language
A = Analysis type

Total number of items in this bibliography: 31

Add all to report

Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Author(s): Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1
Affiliations(s): 1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada.
Publication(s): Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7.
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C: Y:	Obesity, 2019	L: A:	English


Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Author(s): 1. Sean Wharton Wharton Medical Clinic, Burlington, ON, Canada 2. Aiden R Liu Novo Nordisk Canada, Mississauga, ON, Canada 3. Arash Pakseresht Novo Nordisk Canada, Mississauga, ON, Canada 4. Emil Nørtoft Novo Nordisk A/S, Copenhagen, Denmark 5. Christiane L Haase Novo Nordisk A/S, Copenhagen, Denmark 6. Johanna Mancini IQVIA, Montreal, QC, Canada 7. G Sarah Power IQVIA, Mississauga, ON, Canada 8. Sarah VanderLelie Wharton Medical Clinic, Burlington, ON, Canada 9. Rebecca AG Christensen Wharton Medical Clinic, Burlington, ON, Canada
Affiliations(s): 1. Sean Wharton Wharton Medical Clinic, Burlington, ON, Canada 2. Aiden R Liu Novo Nordisk Canada, Mississauga, ON, Canada 3. Arash Pakseresht Novo Nordisk Canada, Mississauga, ON, Canada 4. Emil Nørtoft Novo Nordisk A/S, Copenhagen, Denmark 5. Christiane L Haase Novo Nordisk A/S, Copenhagen, Denmark 6. Johanna Mancini IQVIA, Montreal, QC, Canada 7. G Sarah Power IQVIA, Mississauga, ON, Canada 8. Sarah VanderLelie Wharton Medical Clinic, Burlington, ON, Canada 9. Rebecca AG Christensen Wharton Medical Clinic, Burlington, ON, Canada
Publication(s): ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C: Y:	Obesity, 2018	L: A:	English Retrospective cohort analysis,


Excess Healthcare Resource Utilization in Obesity Pharmacotherapy Candidates in Canada
Author(s): Feroz T1, Charland K2, Heembrock S2, Borrelli R2, Skovgaard R1
Affiliations(s): 1 NovoNordisk Canada Inc. Canada 2 IMS Brogan Canada
Publication(s): 13th International Conference on Obesity, 2016, May 1-4, Vancouver, Canada
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C: Y:	Drug Utlization Study, Obesity, 2016	L: A:	English Retrospective cohort analysis,


Body mass index and all-cause mortality in patients with hypertension
Author(s): Xu W, Shubina M, Goldberg SI & Turchin A
Affiliations(s): Harvard Medical School, Boston
Publication(s): Obesity (Silver Spring) 23(8):1712-20
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C: Y:	Cardiovascular disease, Obesity, 2015	L: A:	English Retrospective database analysis,


Effect of adjustable gastric banding on quality of life and weight loss in the Helping Evaluate Reduction in Obesity (HERO) registry study: 2-year analysis
Author(s): Lao W-L, Malone DC, Armstrong EP, Voellinger D, Somers S, Jin J, Dreyer N, Globe D
Affiliations(s):
Publication(s): Current Medical Research & Opinion 2015: Posted on-line July 8, 2015. doi: 10.1185/03007995.2015.1059802
Document Type(s): Article,
Countries:
C: Y:	Obesity, 2015	L: A:	English RWLPR (Real-World Late Phase Research-quintiles,


Prevalence of Comorbidities and Baseline Characteristics of LAP-BAND AP® Subjects in the Helping Evaluate Reduction in Obesity (HERO) Study
Author(s): Dreyer NA, Dixon JB, Okerson T, Finkelstein EA, Globe D
Affiliations(s):
Publication(s):
Document Type(s): Article,
Countries:
C: Y:	Obesity, 2013	L: A:	English RWLPR (Real-World Late Phase Research-quintiles,


Safety Assessment of an Anti-Obesity drug (Sibutramine)
Author(s): Tyczynski JE1,Oleske DM2, Klingman D3 Ferrufino CP4, Lee WC4
Affiliations(s): 1 Astellas Pharma, Northbrook, IL,USA 2 Abbott Laboratories, Abbott, IL, USA 3 Gainsville, VA, USA 4 IMS Health, Falls Church, VA, USA
Publication(s): Drug Safety 2012;35(8):629-644
Document Type(s): Article,
Countries: Germany, UK,
C: Y:	Obesity, 2012	L: A:	English Retrospective cohort analysis,


Obesity and the risk of psoriatic arthritis: a population-based study.
Author(s): Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, Choi HK.
Affiliations(s): Landspitali University Hospital Department of Science, Education, and Innovation
Publication(s): Ann Rheum Dis. 2012 Aug;71(8):1273-7. doi: 10.1136/annrheumdis-2012-201299. Epub 2012 May 14.
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C: Y:	Obesity, Orthopedics, Rheumatology, 2012	L: A:	English Retrospective database analysis,


OC-038?Healthcare use according to body mass index (BMI) category in individuals registered to GP practices
Author(s): Ashman K E , Cawood A L & Stratton R J
Affiliations(s): Nutricia Medical affairs
Publication(s): Gut2012;61:A16-A17 doi:10.1136/gutjnl-2012-302514a.38
Document Type(s): Abstract, Article,
Countries: UK,
Click here for the abstract
C: Y:	Obesity, 2012	L: A:	English Retrospective database analysis,


Body mass index and obstructive sleep apnoea in the UK: a cross-sectional study of the over-50s.
Author(s): Wall H, Smith C & Hubbard R.
Affiliations(s): NHS Improvement
Publication(s): Prim Care Respir J. 2012 Dec;21(4):371-6. doi: 10.4104/pcrj.2012.00053.
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C: Y:	Mental health, Obesity, 2012	L: A:	English Retrospective database analysis,


1 of 4